GeneralConnection.com ➔ Dictionary
Dictionary Search

haemophilia b

Synonyms

Noun

1. hemophilia B

2. haemophilia B, Christmas disease, hemophilia, haemophilia, bleeder's disease

Usage
How durable is gene therapy for haemophilia B? - Nature
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B - NEJM
Explainer 2025 Why Is Hemophilia B Called Christmas Disease - Global Biotechnology Company
EAHAD 2026: Nine-Year Outcomes of Gene Therapy - EMJ
Gene therapy can help reduce joint bleeds in hemophilia B: New data - Hemophilia News Today
Marstacimab in the treatment of patients with hemophilia A and B - Via Medica Journals
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
First subject dosed in Be Biopharma’s trial of haemophilia B therapy - Clinical Trials Arena
Building safeguards for gene therapy in haemophilia - The Lancet
Hemophilia B gene therapy demonstrates long-term success - St. Jude Children's Research Hospital
Exploring gene editing as a potential therapeutic strategy for hemophilia - Frontiers
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials - Nature
Redefining Hemophilia Management: Treatment Goals, Nonfactor Replacement Therapies, and the Role of Fitusiran - AJMC
First German haemophilia B patient receives gene therapy HEMGENIX - PharmaTimes
Single-Dose Gene Therapy Shows Promising Safety, Efficacy, and Patient-Reported Outcomes in Hemophilia B - Docwire News
New gene therapy reduces bleeding rates for hemophilia B patients - Hemophilia News Today
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B - NEJM
Exploring Eptacog Beta Dosing in Patients With Hemophilia A or B - Docwire News
Patients With Hemophilia Face Significant Burden Despite Treatment Type or Disease Severity - Docwire News
Hemophilia B gene therapy benefits last more than a decade: Study - Hemophilia News Today
Phase 3 Analysis: Concizumab Noninferior to Prior Prophylaxis in Hemophilia A, B, Without Inhibitors - Docwire News
First-in-human trial of hemophilia B treatment BE-101 starts dosing - Hemophilia News Today
(marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
Patient in Germany gets hemophilia B gene therapy Hemgenix - Hemophilia News Today
Five-year study confirms durable efficacy of etranacogene dezaparvovec - PharmaTimes
Haemophilia A vs B: Which is more severe? Here’s what sets them apart - TheHealthSite
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties - Nature
ASH: CSL proves efficacy of hemophilia B gene therapy Hemgenix holds up after 5 years - Fierce Pharma
NICE recommends weekly injection for severe haemophilia B - The Pharmaceutical Journal
First NHS patient treated with CSL Behring’s haemophilia B gene therapy Hemgenix - PMLiVE
Haemophilia treatment guide: What every patient must know - TheHealthSite
Alhemo Indication Expanded to Include Hemophilia A/B Without Inhibitors - MPR - Medical Professionals Reference
Haemophilia gene therapy patients thriving over a decade after treatment | UCL News - UCL - UCL | University College London
Hull teenager first to be treated with new haemophilia drug - BBC
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors - PR Newswire
CSL Behring Signs Letter of Intent with pan-Canadian Pharmaceutical Alliance (pCPA) for Public Reimbursement of HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B - Yahoo Finance
Hemophilia gene therapy: A new era of treatment and the obstacles ahead - Drug Discovery News
Hemophilia B Gene Therapy Shows Promise as Long-Term Treatment - Docwire News
Hemophilia B Pipeline 2026 Report Highlights Next-Gen Gene Therapies, FDA Advances, and Clinical Momentum Across Novo Nordisk, Pfizer, Sanofi & Emerging Biotechs | DelveInsight - Barchart.com
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors - BioSpace
One dose of gene therapy gives years of relief from blood disorder - Nature
Hemophilia prognosis: Life expectancy and outlook - Hemophilia News Today
Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study - NEJM
China Explores Weight-Based Pricing for First Domestic Hemophilia B Gene Therapy - NAVLIN DAILY
Novo Nordisk’s Alhemo approved by FDA for expanded haemophilia use - PMLiVE
Spotlight on the ISTH Hemophilia Treatment Guidelines and Alternate Recommendations - Hematology Advisor
Extended hemophilia half-life products aid care, but raise costs - Hemophilia News Today
Systemic lupus erythematosus caused acquired hemophilia B without evidence of factor IX inhibitors - Wiley Online Library
G-BA Rates “Considerable” Added Benefit of Alhemo for Hemophilia B Patients - NAVLIN DAILY
Hemophilia B Market: Rapid Increment Driven by Innovation - openPR.com
How Fitusiran Changes the Treatment Landscape in Hemophilia: Guy Young, MD - AJMC
NHS treats first haemophilia B patient with gene therapy - Progress Educational Trust
Pfizer reports positive results from Phase III BASIS trial for haemophilia - Clinical Trials Arena
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B - NEJM
FDA expands approvals for Novartis lipid drug, Novo haemophilia prophylatic - FirstWord Pharma
Concizumab approved to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with haemophilia A or B with inhibitors - GOV.UK
Why Hympavzi Secured English Funding For Hemophilia B But Not Hemophilia A - Citeline News & Insights
CSL’s haemophilia therapy shows durable five-year benefits in landmark trial results - Biotech Dispatch
NICE recommends Pfizer’s new once-weekly treatment for haemophilia B on NHS - Pharmafile
The National “New Methods” Decision Forum in Norway recommends CSL’s gene therapy HEMGENIX® for adults with severe or moderately severe haemophilia B without a history of Factor IX inhibitors - Mynewsdesk
First NHS patient given world's most expensive drug that costs £2.6 million per dose - LADbible
How pioneering gene therapy changed the life of the first man in Wales to receive it - Nation.Cymru
Pfizer's weekly haemophilia drug backed for NHS use - pharmaphorum
Non-replacement therapy for people with haemophilia B: another step towards health equity - The Lancet
First gene therapy to treat haemophilia B - European Medicines Agency (EMA)
CDC Hemophilia Mutation Projects (CHAMP and CHBMP) - Centers for Disease Control and Prevention | CDC (.gov)
What is Hemophilia B? - Global Biotechnology Company
Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B - NEJM
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B - NEJM
A Reality Check of Hemophilia Care: What a Real-World Study Says About the Unmet Needs of People With Hemophilia A or B - Managed Healthcare Executive
With hemophilia B, a lifetime of worry eased with one infusion - Penn Today
Six biotech companies leading the charge in hemophilia treatment - Labiotech.eu
First hemophilia B patients in Denmark treated with Hemgenix –... - Hemophilia News Today
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system - Nature
Successful management with regular factor IX replacement during pregnancy in a hemophilia B carrier: A case report - Wiley
First subcutaneous treatment for severe Haemophilia B recommended - National Health Executive
NMPA approves BBM and Takeda China’s haemophilia B therapy - Pharmaceutical Technology
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec) Over Five Years - Mynewsdesk
Breaking ground in haemophilia B gene therapy: insights from the HOPE-B trial and beyond - The Lancet
Transformational therapy cures haemophilia B - BBC
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant - NEJM
Belief, Takeda’s home-grown haemophilia B gene therapy gains nod in China - FirstWord Pharma
Belief BioMed announced BBM-H901 (Dalnacogene Ponparvovec Injection), China's first hemophilia B gene therapy, was officially approved in Macao, China - The Manila Times
Real Stories from People Living with Hemophilia - Centers for Disease Control and Prevention | CDC (.gov)
CSL Behring treats two patients with gene therapy for haemophilia B - Clinical Trials Arena
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors - NEJM
CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice - Nature
UK Approves Marstacimab for Severe Haemophilia A or B - Medscape
Groundbreaking treatment for haemophilia administered in Wales for first time - Nation.Cymru
Haemophilia - The Lancet
Hemophilia B Gene Therapy Produces Durable Response for 90% of Participants - AJMC
uniQure announces FDA approval of first gene therapy for adults with hemophilia B - uniqure.gcs-web.com
Researchers welcome $3.5-million haemophilia gene therapy — but questions remain - Nature
Recombinant factor IX Fc fusion protein in children with haemophilia B (Kids B-LONG): results from a multicentre, non-randomised phase 3 study - The Lancet
Single-dose gene therapy is potentially life-changing for adults with hemophilia B - Penn Medicine
Phase 1/2 clinical trial of BE-101 now enrolling hemophilia B patients - Hemophilia News Today
Freeline Therapeutics doses first subject in haemophilia B therapy trial - Clinical Trials Arena
News and Expert Insights in Hemophilia Gene Therapy for Bleeding Disorders Awareness Month 2025 - CGTLive®
Intellia ending work with Regeneron on gene therapy for hemophilia B - Hemophilia News Today
After 4 years, hemophilia B bleeding rates remain low with Hemgenix - Hemophilia News Today
Foreign Language Equivalents
Foreign Language Equivalents of 'haemophilia b'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
haemophiliaa b,   haemopilia b,   haemohilia b,   haemoophilia b,   hamophilia b,   haemohpilia b,   haemophiila b,   haeomphilia b,   haemmophilia b,   haemophilia bb,   haeophilia b,   haemophiliia b,   heamophilia b,   haemophiliab ,   hawmophilia b,   haemophili ab,   haemophilia ,   haemopholia b,   haemophila b,   hemophilia b,   haemopphilia b,   haemophilai b,   aemophilia b,   haemopgilia b,   harmophilia b,   hhaemophilia b,   haemophili b,   haemophilis b,   haenophilia b,   haemophiilia b,   hsemophilia b,   haemophilua b,   haemophilia b,   gaemophilia b,   haempohilia b,   haaemophilia b,   haemophillia b,   haemophiloa b,   jaemophilia b,   haemophiia b,   haemophilia v,   haemoohilia b,   haemophiliab,   haemophlia b,   hameophilia b,   hae,ophilia b,   haemophi;ia b,   haeemophilia b,   ahemophilia b,   haemophikia b,   haemophliia b,   haemopihlia b,   haemiphilia b,   haemopjilia b,   haemophilia n,   haemo[hilia b,   haempphilia b,   haemphilia b,   haemophulia b,   haemophhilia b
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z